Weight Loss Apr 29, 2026
Meta-analysis · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Tirzepatide Lowers Heart Attack and Stroke Risks in Diabetes

A new analysis of real-world data reveals that the popular medication tirzepatide significantly lowers the risk of heart attacks, stroke, and early death in people with type 2 diabetes.

Read Analysis
Weight Loss Apr 29, 2026
Cohort study · The Lancet Psychiatry

Popular Diabetes Drugs May Protect Against Worsening Mental Health

New research suggests that medications like semaglutide could actually protect against worsening anxiety and depression rather than exacerbating them.

Read Analysis
Weight Loss Apr 22, 2026
Animal study · Cell metabolism

Semaglutide Protects Against Osteoarthritis Even Without Weight Loss

Semaglutide could relieve osteoarthritis pain and repair cartilage by changing how joint cells use energy, rather than just by shedding pounds.

Read Analysis
Weight Loss Apr 22, 2026
Other · Hepatology (Baltimore, Md.)

New Guidelines: How Semaglutide Treats Fatty Liver Disease

Liver experts have released new guidelines on using the popular drug semaglutide to treat a serious form of fatty liver disease.

Read Analysis
Weight Loss Apr 19, 2026
Systematic review · The Cochrane database of systematic reviews

Intermittent Fasting Works No Better Than Traditional Dieting Advice

A comprehensive review of 22 clinical trials reveals that intermittent fasting doesn't offer a magic bullet for shedding pounds compared to standard dietary guidance.

Read Analysis
Weight Loss Apr 19, 2026
Cohort study · Journal of Endocrinological Investigation

Tirzepatide Outperforms Semaglutide in Real-World Six-Month Comparison

A real-world comparison reveals that tirzepatide drives significantly greater results than semaglutide over six months.

Read Analysis